| Day 2 - Saturday, April 4, 2009 |
| 0800 - 0945 hrs |
GU Cancer Lectures (Theatre)
Moderator: TAY Miah Hiang, Singapore |
| 0800 - 0830 hrs |
The molecular characterization of renal cell carcinoma
- TEH Bin Tean, USA |
| 0830 - 0900 hrs |
Angiogenesis inhibitors' in renal cell cancer: current status and future directions
- Primo LARA, USA |
| 0900 - 0930 hrs |
mTor inhibitors renal cancer
- Ken PITTMAN, Australia |
| 0930 - 0945 hrs |
Questions & Answers |
| 0945 - 1030 hrs |
Gynaecological Oncology Lecture (Theatre)
Moderator: SEE Hui-Ti, Singapore |
| 0945 - 1020 hrs |
Targeted therapies in gynaecologic cancer: Promises and constraints
- John KAVANAGH, USA |
| 1020 - 1030 hrs |
Questions and Answers |
| 1030 - 1045 hrs |
Tea Break - Exhibition |
| |
Haemato-Oncology Suite
-
Meeting
Room 301 |
Breast
Cancer Suite
-
Meeting
Room 302 |
Lung
Cancer Suite
-
Meeting
Room 303 |
Gynaecological
Oncology Suite
-
Meeting
Room 304 |
Gastrointestinal Cancer Suite
-
Meeting
Room 305 |
Head & Neck
Cancer Suite
-
Meeting
Room 306 |
| 1045 - 1145 hrs |
HO
Symposium
1
(Understanding the
Pathology of
Peripheral T cell
Lymphoma and
NK/T
cell lymphoma)
Moderator: Ivy SNG, Singapore, A Harryanto REKSODIPUTRO, Indonesia |
BC
Symposium
1
(Cancer Biology/Cancer Screening and Prevention/ Hereditary Breast Cancer)
Moderators: Peter ANG, Singapore |
LC
Symposium
1
(Lung Cancer Biology (I))
Moderator: Darren LIM, Singapore |
GC
Symposium
1
(Chemotherapy And New Therapeutic Cancer Treatment)
Moderator: Sarikapan WILAILAK, Thailand |
HO
Symposium
1
(Adjuvant Therapy and Palliative Chemotherapy)
Moderater: CHUNG Hyun-Cheol, Korea |
HNC
Symposium
1
(SCCHN in Resource Scarce Situations)
Moderator: Joseph WEE, Singapore |
| 1045 - 1115 hrs |
Pathological
charactersitics
of T-cell
lymphoma
- Leonard TAN, Singapore |
The breast cancer epidemic in Asia
- HAN Sehwan,
South Korea |
Proposed new pathologic classification of
lung cancer
- Peter GOLDSTRAW, UK
|
New therapeutic agents for epithelial ovarian cancers
- John KAVANAGH,
USA |
S1 – The new
standard of care
in metastatic
gastric cancers?
- RHA Sun Young, South Korea |
Head and neck squamous cell carcinoma: Where next in radiation dose fractionation?
- Soren BENTZEN, USA |
| 1115 - 1145 hrs |
Pathological charactersitics of NK/T cell lymphoma
- TAN Soo Yong, Singapore |
Mammogram, ultrasound or MRI in breast cancer screening and pre-operative assessment
- SHAO Zhi-Ming,
China |
Genetic and environmental influences on lung cancer risk in an Asian population
- Adeline SEOW, Singapore |
Systemic
treatment for
advanced
endometrial
cancer - A review
- SEE Hui-Ti,
Singapore |
Chemoradiotherapy
or chemotherapy
alone in adjuvant
treatment of gastric
cancers?
- BANG Yung-Jue,
South Korea |
Developing Guidelines for SCCHN
- Anil D'CRUZ, India |
| 1145 - 1245 hrs |
HO
Symposium
2
(Research and
novel strategies
in the therapy of
PTCLs)
Moderator: Miriam TAO, Singapore, Zubairi DJOERBAN, Indonesia |
BC
Symposium
1 (Con't)
(Cancer Biology/Cancer Screening and Prevention/ Hereditary Breast Cancer)
Moderator: YIP Cheng Har, Malaysia |
LC
Symposium
2
Lung Cancer
Biology (II)
Moderator: Darren LIM, Singapore |
GC
Symposium
2
(Epithelial Ovarian Cancer Treatment)
Moderator: LAI Chyong-Huey, Taiwan |
GI
Symposium
2
(Screening And
Management
Challenges in
Hepatocellular
Carcinoma)
Moderators: London Lucien OOI, Singapore, CHOW Wan Cheng, Singapore |
HNC
Symposium
2
(NPC - Treatment for Primary Disease)
Moderator: Anthony CHAN, Hong Kong |
| 1145 - 1215 hrs |
PTCL and NK/T cell
lymphoma: Challenges
and opportunities
- Ranjana ADVANI,
USA |
Diagnosis and intervention for hereditary breast cancer in Asian women: BRCA and beyond
- LEE Soo Chin, Singapore |
Gender differences in lung cancer
- Julie BRAHMER, USA |
Gynaecological experience in bowel surgery for ovarian cancer
(20 mins)
- A Z Hatta MD DALI
|
Will managing chronic viral hepatitis well reduce occurrence of HCC?
- CHOW Wan Cheng, Singapore |
Intensity-modulated radiotherapy for nasopharyngal carcinoma
- Daniel CHUA, Hong Kong SAR |
| 1215 - 1245 hrs |
The Asia Pacific
T Cell Network
case studies
- KWONG Yok Lam, Hong Kong SAR |
Hereditary breast cancer research in Asia – a glimmer of hope
- Peter ANG, Singapore
|
Never smokers in NSCLC - a different entity
- TOH Chee Keong, Singapore |
Palliative surgery for gynaecological cancers (20 mins)
- CHIA Yin-Nin,
Singapore |
Challenges in
management of hepatocellular
carcinoma - 3
Interactive
Case Studies
- London Lucien OOI, Singapore |
Overview of clinical trials in nasopharyngeal cancer
- Anne LEE, Hong Kong SAR |
| |
|
Breast cancer prevention: Exercise, diet, body mass, drugs and insulin and IGF signaling pathways
- Kathleen PRITCHARD, Canada |
|
Discussion
(20 mins) |
|
|
| 1245 - 1345 hrs |
Pfizer Lunch Symposium (Gallery East, Level 3)
Management of mRCC in the era of targeted therapy
Chair: KONG Hwai Loong
Speaker: TAN Min Han, Singapore
Speaker: Primo N. LARA, Jr, USA
Speaker: TOH Chee Keong, Singapore |
| |
Haemato-Oncology Suite
-
Meeting
Room 301 |
Breast
Cancer Suite
-
Meeting
Room 302 |
Lung
Cancer Suite
-
Meeting
Room 303 |
Gynaecological
Oncology Suite
-
Meeting
Room 304 |
Gastrointestinal Cancer Suite
-
Meeting
Room 305 |
Head & Neck
Cancer Suite
-
Meeting
Room 306 |
| 1345 - 1445 hrs |
HO
Symposium
3
(Understanding B cell lymphoma (I))
Moderator: LIM Soon Thye, Singapore, Abidin WIDJANARKO, Indonesia |
BC
Symposium
2
(Preoperative Chemotherapy As A Platform for Improving Patient Care And Research)
Moderators: KHOO Kei Siong, Singapore, Kathleen PRITCHARD, Canada |
LC
Symposium
3
(Early Detection)
Moderator: LIAO Meilin, China |
GC
Symposium
3
(Laproscopic Surgery for Gynaecological Cancers)
Moderator: Effren DOMINGO, Philippines |
GI
Symposium
3
(SIRT in HCC And APHCC Trials Group)
Moderators: Pierce CHOW, Singapore, Joseph LAU, Hong Kong SAR |
HNC
Symposium
3
(NPC - Treatment for Advanced / Metastatic Disease)
Moderator: Joseph WEE, Singapore |
| 1345 - 1415 hrs |
Understanding the pathology of Lymphomas: Can we make some sense of it?
- Leonard TAN,
Singapore |
Lessons from preoperative chemotherapy trials: opportunities and limitations for patient care and clinical research
- WONG Nan Soon, Singapore |
CT scan screening for lung cancer
- Lou IRVING, Australia |
Minimally invasive surgery for gynecological cancer: Experiences in Asia-Pacific region
- KIM Young-Tak, South Korea |
Selective internal radiotherapy for hepatocellular carcinoma
- Joseph LAU,
Hong Kong |
Systemic therapy - Old and new approaches
- Brigette MA, Hong Kong SAR |
| 1415 - 1445 hrs |
Controversies in the management of low grade B cell lymphoma
- Alexandra LEVINE,
USA |
Biomarker discoveries from preoperative chemotherapy trials
- Jenny CHANG,
USA |
Autofluorescence bronchoscopy in the early detection of lung cancer
- Pyng LEE, Singapore |
Technique and perioperative outcomes of laparoscopic hysterectomy and pelvic lymphadenectomy for endometrial cancer
- TAY Eng-Hseon, Singapore |
The Asia Pacific Hepatocellular
Carcinoma Trials
Group Experience
- Pierce CHOW,
Singapore |
Immunotherapeutic approaches
- TOH Han Chong, Singapore |
| |
|
|
|
Discussion: MIS surgery for gynae cancers (20 mins) |
|
|
| 1445 - 1545 hrs |
HO
Symposium
4
(Understanding B cell lymphoma (II))
Moderator: Daryl TAN, Singapore, Noorwati SUTANDIO, Indonesia |
BC
Symposium
2 (con't)
(Preoperative Chemotherapy As A Platform for Improving Patient Care And Research )
|
LC
Symposium
4
(Local Therapeutics: Radiotherapy and Radiofrequency)
Moderator: Peter GOLDSTRAW, UK |
GC
Symposium
4
(Adjuvant Radiotherapy for Gynaecological Cancers )
Moderator: KHOO-TAN Hoon Seng, Singapore |
GI
Symposium
4
(Cholangiocarcinoma)
Moderators: Alexander CHUNG, Singapore, TEH Bin Tean, USA |
HNC
Symposium
4
(NPC - Diagnostic and Molecular Research)
Moderator: Anthony CHAN, Hong Kong |
| 1445 - 1515 hrs |
Controversies in the management of aggressive B cell lymphoma
- Ranjana ADVANI, USA |
Sentinel lymph node biopsy: before or after preoperative chemotherapy?
- Louis CHOW,
Hong Kong SAR |
Adjuvant radiotherapy in resected NSCLC – when to use it?
- FONG Kam Weng, Singapore |
Adjuvant radiotherapy for endometrial cancer - scenarios voting and discussion |
The molecular characterization of cholangiocarcinoma
- TEH Bin Tean, USA |
FDG PET in oral squamous cell carcinoma
- Dorothy YEN, Taiwan |
| 1515 - 1545 hrs |
Radioimmunotherapy
in B cell lymphoma
- KIM Won Seog, South Korea |
Factors determining local recurence and impact on radiotherapy considerations in preoperative chemotherapy
- PK Julka, India |
Radiofrequency ablation in lung cancer
- Karin STEINKE, Australia |
Adjuvant radiotherapy for endometrial cancer - Review of Asian Protocol
- LEE Khai Mun, Singapore |
Challenges In
management of cholangiocarcinoma
– 3 Interactive
Case Studies
- Alexander CHUNG Yaw Fui, Singapore |
Molecular research in metastasis of NPC
- QIAN Chao-Nan, China |
| 1545 - 1600 hrs |
Tea Break - Exhibition |
| |
Haemato-Oncology Suite
-
Meeting
Room 301 |
Breast
Cancer Suite
-
Meeting
Room 302 |
Lung
Cancer Suite
-
Meeting
Room 303 |
Gynaecological
Oncology Suite
-
Meeting
Room 304 |
Gastrointestinal Cancer Suite
-
Meeting
Room 305 |
Head & Neck
Cancer Suite
-
Meeting
Room 306 |
| 1600 - 1700 hrs |
HO
Symposium
5
(Plasma cell disorders/Thrombosis in cancer )
Moderator: William HWANG, Singapore, Aru SUDOYO, Indonesia |
BC
Symposium
3
(Advanced Breast Cancer/ Survivorship/ QOL/ Palliative Care)
Moderators: HSIEH Ruey-Kuen, Taiwan, SHAO Zhi-Ming, China |
LC
Symposium
5
(Management of Advanced Stage NSCLC)
Moderator: Julie BRAHMER, USA |
GC
Symposium
5
(Progress update)
Moderator: KIM Young-Tak, South Korea |
GI
Symposium
5
(Liver Metastasectomy and Novel Agents in CRC)
Moderators: Simon ONG, Singapore, TAN Yu Meng, Singapore |
HNC
Symposium
5
(SCCHN) - "Targeted Therapy (I)"
Moderator: Joseph WEE, Singapore |
| 1600 - 1630 hrs |
Multiple Myeloma: From Genetics to Therapeutics
- CHNG Wee Joo, Singapore |
Patient advocacy and survivorship issues for breast cancer patients
- Fran BOYLE, Australia
|
First line treatment of advanced stage NSCLC
- Chih-Hsin James YANG, Taiwan |
Current controversies on HPV vaccines
- Efren DOMINGO, Philippines |
Liver
metastasectomy in colorectal cancer
- Who, when, how
- TAN Yu Meng, Singapore |
Biological Adaptive IGRT
- Vincent GREGOIRE, Belgium |
| 1630 - 1700 hrs |
Venous thromboembolism and cancer
- LEE Lai Heng, Singapore |
Revisiting chemotherapy strategies in advanced breast cancer: schedule, dose and duration
- Narin VORAVUD,
Thailand |
Second/ third line treatments for advanced stage NSCLC
- Cho Byoung Chul, South Korea |
The role of PET scan in gynaecological cancers
- LAI Chyong-Huey, Taiwan |
Optimal management of metastatic colorectal cancer
- Simon ONG,
Singapore |
Carbon ion radiotherapy for head and neck cancers
- Hirohiko TSUJII, Japan |
| 1700 - 1800 hrs |
HO
Symposium
6
(Myeloproliferative disorders)
Moderator: NG Heng Joo, Singapore, Karmel L TAMBUNAN, Indonesia |
BC
Symposium
3 (con't)
(Advanced Breast Cancer/ Survivorship/ QOL/ Palliative Care) |
LC
Symposium
6
(Biomarker and Novel Therapeutics)
Moderator: Chih-Hsin James YANG, Taiwan |
GC
Symposium
6
(Progress update)
Moderator: CHIA Yin-Nin, Singapore |
GI
Symposium
6
(Gastropancreatic Neuroendocrine Tumours)
Moderators: Larry KVOLS, USA, Jeffrey TZEN, Taiwan |
HNC
Symposium
6
(SCCHN) - "Targeted Therapy (II)"
Moderator: Joseph WEE, Singapore |
| 1700 - 1730 hrs |
Targeting the T315I mutant and the leukaemic stem cell – the next therapeutic challenge for CML
- Charles CHUAH, Singapore |
Overcoming breast cancer treatment resistance: exploiting cross talk in cell signaling pathways
- Jenny CHANG,
USA |
Biomarkers - are we there yet?
- WU Yi Long, China |
Adjuvant treatment in cervical cancer
- Sarikapan WILAILAK, Thailand |
Pathology of gastroenteropancreatic
neuroendocrine
tumours - Forging a common language.
- Jeffrey TZEN, Taiwan |
"Targeted Surgery" for SCCHN
- Christopher GOH, Singapore |
| 1730 - 1800 hrs |
Myeloproliferative Neoplasia
- ONG Kiat Hoe, Singapore |
Should mastectomy and metastasectomy be offered to women with advanced breast cancer?
- YIP Cheng Har, Malaysia |
Emerging agents targeting EGFR, VEGF and beyond in NSCLC
- Mark VINCENT, Canada |
Pelvic exenteration in cervical cancer
-
Wisit SUPAKARAPONGKUL, Thailand |
Case studies in gastroenteropancreatic neuroendocrine tumours
- Larry KVOLS, USA |
"Targeted" systemic therapy for SCCHN
- Mohammed Ibrahim A WAHID, Malaysia |
| End of Day 2 |
